Influence of antileukemic (L1210) treatment schedule on disposition of (minus)-emetine hydrochloride (NSC 33669) in normal and leukemic mice.
D000284:Administration, Oral; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use; D004640:Emetine / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use / Q000652:urine; D005243:Feces / Q000032:analysis; D007274:Injections, Intraperitoneal; D007421:Intestine, Small / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D013050:Spectrometry, Fluorescence; D013154:Spleen / Q000378:metabolism
D000970:Antineoplastic Agents; D004640:Emetine